BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26842889)

  • 1. UMD-Predictor: A High-Throughput Sequencing Compliant System for Pathogenicity Prediction of any Human cDNA Substitution.
    Salgado D; Desvignes JP; Rai G; Blanchard A; Miltgen M; Pinard A; Lévy N; Collod-Béroud G; Béroud C
    Hum Mutat; 2016 May; 37(5):439-46. PubMed ID: 26842889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UMD-predictor, a new prediction tool for nucleotide substitution pathogenicity -- application to four genes: FBN1, FBN2, TGFBR1, and TGFBR2.
    Frédéric MY; Lalande M; Boileau C; Hamroun D; Claustres M; Béroud C; Collod-Béroud G
    Hum Mutat; 2009 Jun; 30(6):952-9. PubMed ID: 19370756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of RNA- and exome sequencing: Increasing specificity for identification of somatic point mutations and indels in acute leukaemia.
    Hansen MC; Herborg LL; Hansen M; Roug AS; Hokland P
    Leuk Res; 2016 Dec; 51():27-31. PubMed ID: 27821287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.
    Waldmüller S; Schroeder C; Sturm M; Scheffold T; Imbrich K; Junker S; Frische C; Hofbeck M; Bauer P; Bonin M; Gawaz M; Gramlich M
    Mol Cell Probes; 2015 Oct; 29(5):308-14. PubMed ID: 25979592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Pathogenicity Prediction Tools on Somatic Variants.
    Suybeng V; Koeppel F; Harlé A; Rouleau E
    J Mol Diagn; 2020 Dec; 22(12):1383-1392. PubMed ID: 33011441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Broad Overview of Computational Methods for Predicting the Pathophysiological Effects of Non-synonymous Variants.
    Castellana S; Fusilli C; Mazza T
    Methods Mol Biol; 2016; 1415():423-40. PubMed ID: 27115646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VarAFT: a variant annotation and filtration system for human next generation sequencing data.
    Desvignes JP; Bartoli M; Delague V; Krahn M; Miltgen M; Béroud C; Salgado D
    Nucleic Acids Res; 2018 Jul; 46(W1):W545-W553. PubMed ID: 29860484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WES/WGS Reporting of Mutations from Cardiovascular "Actionable" Genes in Clinical Practice: A Key Role for UMD Knowledgebases in the Era of Big Databases.
    Pinard A; Salgado D; Desvignes JP; Rai G; Hanna N; Arnaud P; Guien C; Martinez M; Faivre L; Jondeau G; Boileau C; Zaffran S; Béroud C; Collod-Béroud G
    Hum Mutat; 2016 Dec; 37(12):1308-1317. PubMed ID: 27647783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of function of PGAP1 as a cause of severe encephalopathy identified by Whole Exome Sequencing: Lessons of the bioinformatics pipeline.
    Granzow M; Paramasivam N; Hinderhofer K; Fischer C; Chotewutmontri S; Kaufmann L; Evers C; Kotzaeridou U; Rohrschneider K; Schlesner M; Sturm M; Pinkert S; Eils R; Bartram CR; Bauer P; Moog U
    Mol Cell Probes; 2015 Oct; 29(5):323-9. PubMed ID: 26050939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From Wet-Lab to Variations: Concordance and Speed of Bioinformatics Pipelines for Whole Genome and Whole Exome Sequencing.
    Laurie S; Fernandez-Callejo M; Marco-Sola S; Trotta JR; Camps J; Chacón A; Espinosa A; Gut M; Gut I; Heath S; Beltran S
    Hum Mutat; 2016 Dec; 37(12):1263-1271. PubMed ID: 27604516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mirTrios: an integrated pipeline for detection of de novo and rare inherited mutations from trios-based next-generation sequencing.
    Li J; Jiang Y; Wang T; Chen H; Xie Q; Shao Q; Ran X; Xia K; Sun ZS; Wu J
    J Med Genet; 2015 Apr; 52(4):275-81. PubMed ID: 25596308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole exome sequencing combined with integrated variant annotation prediction identifies asymptomatic Tangier disease with compound heterozygous mutations in ABCA1 gene.
    Tada H; Kawashiri MA; Nohara A; Saito R; Tanaka Y; Nomura A; Konno T; Sakata K; Fujino N; Takamura T; Inazu A; Mabuchi H; Yamagishi M; Hayashi K
    Atherosclerosis; 2015 Jun; 240(2):324-9. PubMed ID: 25875382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
    Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
    Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in exome analysis by LifeScope and its alternative computational pipelines.
    Pranckevičiene E; Rančelis T; Pranculis A; Kučinskas V
    BMC Res Notes; 2015 Sep; 8():421. PubMed ID: 26346699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UMD-USHbases: a comprehensive set of databases to record and analyse pathogenic mutations and unclassified variants in seven Usher syndrome causing genes.
    Baux D; Faugère V; Larrieu L; Le Guédard-Méreuze S; Hamroun D; Béroud C; Malcolm S; Claustres M; Roux AF
    Hum Mutat; 2008 Aug; 29(8):E76-87. PubMed ID: 18484607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated next-generation sequencing analysis of whole exome and 409 cancer-related genes.
    Shimoda Y; Nagashima T; Urakami K; Tanabe T; Saito J; Naruoka A; Serizawa M; Mochizuki T; Ohshima K; Ohnami S; Ohnami S; Kusuhara M; Yamaguchi K
    Biomed Res; 2016; 37(6):367-379. PubMed ID: 28003584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replicate exome-sequencing in a multiple-generation family: improved interpretation of next-generation sequencing data.
    Cherukuri PF; Maduro V; Fuentes-Fajardo KV; Lam K; ; Adams DR; Tifft CJ; Mullikin JC; Gahl WA; Boerkoel CF
    BMC Genomics; 2015 Nov; 16():998. PubMed ID: 26602380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple and efficient identification of rare recessive pathologically important sequence variants from next generation exome sequence data.
    Carr IM; Morgan J; Watson C; Melnik S; Diggle CP; Logan CV; Harrison SM; Taylor GR; Pena SD; Markham AF; Alkuraya FS; Black GC; Ali M; Bonthron DT
    Hum Mutat; 2013 Jul; 34(7):945-52. PubMed ID: 23554237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mit-o-matic: a comprehensive computational pipeline for clinical evaluation of mitochondrial variations from next-generation sequencing datasets.
    Vellarikkal SK; Dhiman H; Joshi K; Hasija Y; Sivasubbu S; Scaria V
    Hum Mutat; 2015 Apr; 36(4):419-24. PubMed ID: 25677119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in detecting genetic alterations and their association with human disease.
    Schwartz CE; Chen CF
    J Mol Biol; 2013 Nov; 425(21):3914-8. PubMed ID: 23876707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.